Regional Cancer Care Associates (RCCA), one of the nation’s largest networks of oncology specialists, has announced that New Jersey Cancer Care, PA and its eight medical oncologists/hematologists will be joining the RCCA ranks effective July 1, 2024.
“We are delighted to welcome New Jersey Cancer Care to RCCA, and look forward to working with the practice and its medical oncologists/hematologists as they continue to offer outstanding care to their patients,” said Terrill Jordan, the president and chief executive officer of RCCA. Headquartered in Teaneck, NJ, the RCCA network includes more than 100 cancer specialists providing comprehensive care in 22 community-based offices in New Jersey, Connecticut, Maryland, and the Washington, DC area.has
James M. Orsini, MD, the founder of New Jersey Cancer Care, said, “Regional Cancer Care Associates is a perfect fit for our practice because RCCA shares our commitment to ensuring that patients can receive cutting-edge therapies and access to clinical trials in convenient, welcoming settings close to their homes. Further, like New Jersey Cancer Care, RCCA is dedicated to preserving physician autonomy and leadership, which is critical to ensuring that all decisions are made with the best interest of the patient in mind. The ability to draw on RCCA’s data analytics and many other resources will power our ongoing efforts to individualize treatment decisions to optimal effect and to provide high-quality, compassionate care in the most efficient manner possible.”
With offices in Belleville, Montclair, and Roselle, NJ, New Jersey Cancer Care offers area residents treatment for solid tumors, hematologic malignancies, and non-cancerous blood conditions, such as anemia and clotting disorders. The practice also helps drive advances in cancer care by participating in several clinical trials. In addition to Dr. Orsini, New Jersey Cancer Care’s clinicians include John A. Conti, MD; James Orsini, Jr, MD; Said Saleh, MD; Hemalatha Vasireddy, MD; Sita Yerramalli, MD; Sana Najib, MD; Hafsa Farooq, MD; Ruby Basilio, NP; Eugenie Chetangie, NP; Kyung Chu, PhD, NP; Susan Harrison, NP; and Ashley Rombough, NP.
Iuliana Shapira, MD, the Chief Medical Officer of RCCA, said, “I am thrilled to welcome my colleagues from New Jersey Cancer Care to the RCCA fold. I look forward to all of us working together and learning from one another as we draw on the scientific evidence and our collective experience to further enhance outcomes and quality of life for our patients.”
About RCCA
Established in 2012, Regional Cancer Care Associates (RCCA) has 90+ cancer specialists providing community-based care in 22 offices in New Jersey, Connecticut, Maryland, and the Washington, DC area. RCCA oncologists and hematologists see more than 26,000 new patients each year and provide care to more than 245,000 established patients, collaborating closely with those patients’ other physicians. RCCA specialists offer patients innovative therapies, including immunotherapies and targeted therapy, as well as access to approximately 300 clinical trials. In addition to serving patients who have solid tumors, blood-based cancers, and benign blood disorders, RCCA care centers also provide infusion services to people with a number of non-oncologic conditions—including multiple sclerosis, Crohn’s disease, asthma, iron-deficiency anemia, and rheumatoid arthritis—who take intravenously-administered medications.
About New Jersey Cancer Care
New Jersey Cancer Care has served the community for more than 40 years, providing care with compassion to people facing a wide range of cancers and blood disorders. The practice’s board-certified and fellowship-trained physicians have received dozens of honors and awards for outstanding care, including the Top Docs Award for Quality Care, the NJ Top Doctor Award, and the New Jersey Monthly Jersey Choice Top Doctor
The comprehensive services that New Jersey Cancer Care offers patients include a thorough screening and diagnostic process that draws on advances in imaging, genomics, and other fields; an on-site laboratory for efficient and timely processing of blood work and other tests; fully equipped infusion centers; and a robust clinical research department.
The practice’s physicians have privileges at numerous area hospitals, including Clara Maass Medical Center, where Dr. Orsini serves as Director of Oncology; Hackensack Meridian Health – Mountainside Medical Center; RWJ University Hospital Rahway; and Saint Barnabas Medical Center.
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates (RCCA), one of the nation’s largest networks of oncology specialists, today announced that Hematology Oncology Specialists of Cape Cod (HOSCC) and its three medical oncologists/hematologists will join RCCA.
RCCA is pleased to announce the recognition of John Theurer Cancer Center as the #1 Cancer Program in New Jersey by U.S. News and World Report.
Regional Cancer Care Associates (RCCA), one of the nation’s largest cancer care networks, offers Marylanders access to some of the nation’s leading oncologists and hematologists.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.
